# Horizon-Miss-2026-02-Cancer-02

**Funder:** European Commission
**Budget:** Around €15M
**Deadline:** 15 September 2026 (17:00 Brussels time)
**Consortium:** Required — minimum 3 entities from 3 EU member states
**Application:** Single-stage
**Frequency:** One-off
**Official call:** https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/calls-for-proposals?callIdentifier=HORIZON-MISS-2026-02
**Last verified:** 18 June 2026

## Eligibility & scope

Horizon Europe RIA under the Cancer Mission (Supporting the implementation of the Cancer Mission call HORIZON-MISS-2026-02). Single grant expected. Full topic description available in the call portal.

## Summary

Horizon-MISS-2026-02 is a Horizon Europe Research and Innovation Action (RIA) supporting the European Cancer Mission, with a budget around €15 million for a single award. The call requires a multinational consortium of at least three entities from three different EU member states. This one-off call funds ambitious, cross-border cancer research projects aligned with the Cancer Mission's strategic goals.

## Who should apply

- Research institutions, universities, or clinical centres in EU member states
- Consortium leads capable of coordinating at least 3 organisations across 3 countries
- Teams with demonstrated expertise in cancer research aligned with the Cancer Mission priorities
- Organisations with prior Horizon Europe programme experience or strong track records in large collaborative grants

## Key dates

- Deadline: 15 September 2026, 17:00 Brussels time
- Single-stage evaluation
- One-off call (not recurring)

## Tips for applicants

- Consortium composition is gating: ensure all partners are confirmed and signed off before submission; late additions or weak justification for geographic spread will weaken the proposal.
- The Cancer Mission framework is specific; align your project narrative and objectives explicitly to the published Cancer Mission goals and workstreams to avoid misalignment penalties.
- RIA calls favour ambitious, high-risk research with clear innovation potential; include risk mitigation and feasibility pathways, especially for novel approaches.

## Frequently asked questions

### How much funding does Horizon-MISS-2026-02 offer?

Around €15 million for a single grant.

### Who can apply to Horizon-MISS-2026-02?

Consortia of at least three entities from three different EU member states, including research institutions, universities, and clinical centres.

### What is the deadline for Horizon-MISS-2026-02?

15 September 2026 at 17:00 Brussels time.

### Is Horizon-MISS-2026-02 a recurring call?

No, this is a one-off call under the Cancer Mission.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/european-commission-horizon-miss-2026-02-cancer-02) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.